Human Tissue Microarray (SO053-01A)
Soft Tissue Tumor Tissue Microarray - 1 core per case
- 53 Liposarcoma cases
$225.00
| Species | Human |
|---|---|
| Section Thickness | 5 µm |
| Fixative | Formalin |
| Total Cases | 53 |
| Total Cores | 53 |
| Core Diameter | 1.5 mm |
| Storage | Short term RT |
| Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- B
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- C
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- D
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- E
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- F
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- SO
- G
- SO
- SO
- SO
- SO
- SO
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
| No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Block ID |
|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
A1
|
76
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP1
|
|
2
|
A2
|
52
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP2
|
|
3
|
A3
|
29
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP4
|
|
4
|
A4
|
41
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP6
|
|
5
|
A5
|
48
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP7
|
|
6
|
A6
|
30
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP8
|
|
7
|
A7
|
46
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP9
|
|
8
|
A8
|
47
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP10
|
|
9
|
B1
|
67
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP12
|
|
10
|
B2
|
60
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP14
|
|
11
|
B3
|
71
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP15
|
|
12
|
B4
|
45
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP17
|
|
13
|
B5
|
49
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP18
|
|
14
|
B6
|
39
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP19
|
|
15
|
B7
|
36
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP20
|
|
16
|
B8
|
74
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP21
|
|
17
|
C1
|
41
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP22
|
|
18
|
C2
|
70
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP23
|
|
19
|
C3
|
56
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP24
|
|
20
|
C4
|
55
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP25
|
|
21
|
C5
|
33
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP27
|
|
22
|
C6
|
56
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP28
|
|
23
|
C7
|
54
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP29
|
|
24
|
C8
|
59
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP30
|
|
25
|
D1
|
72
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP31
|
|
26
|
D2
|
56
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP33
|
|
27
|
D3
|
40
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP34
|
|
28
|
D4
|
36
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP35
|
|
29
|
D5
|
33
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP36
|
|
30
|
D6
|
75
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP38
|
|
31
|
D7
|
58
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP39
|
|
32
|
D8
|
28
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP40
|
|
33
|
E1
|
32
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP41
|
|
34
|
E2
|
24
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP42
|
|
35
|
E3
|
64
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP45
|
|
36
|
E4
|
60
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP46
|
|
37
|
E5
|
67
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LIP49
|
|
38
|
E6
|
70
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP51
|
|
39
|
E7
|
43
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP55
|
|
40
|
E8
|
57
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP58
|
|
41
|
F1
|
71
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP59
|
|
42
|
F2
|
65
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LIP61
|
|
43
|
F3
|
57
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP64
|
|
44
|
F4
|
43
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
III
|
Malignant Primary
|
LIP70
|
|
45
|
F5
|
32
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP71
|
|
46
|
F6
|
37
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
III
|
Malignant Primary
|
LIP72
|
|
47
|
F7
|
39
|
F
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
III
|
Malignant Primary
|
LP-107
|
|
48
|
F8
|
54
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LP-117
|
|
49
|
G1
|
59
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
III
|
Malignant Primary
|
LP-118
|
|
50
|
G2
|
34
|
F
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LP-120
|
|
51
|
G3
|
55
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2bN0M0
|
IIB
|
Malignant Primary
|
LP-113
|
|
52
|
G4
|
30
|
M
|
Soft Tissue
|
Liposarcoma
|
G2
|
T2aN0M0
|
IIB
|
Malignant Primary
|
LP-96
|
|
53
|
G5
|
52
|
M
|
Soft Tissue
|
Liposarcoma
|
G3
|
T2aN0M0
|
III
|
Malignant Primary
|
LP-90
|
